EY has promoted Pamela Spence to the role of Global Life Sciences Industry Leader. Based in London, Spence is tasked with further expanding the firm’s footprint in the sector – which houses many of the firm’s largest clients globally.
Pamela Spence has been with EY since joining the firm from PwC in 1998. She has held various role of increasing seniority at the firm in the intervening years, including Global Client Service Partner in Pharmaceuticals, which she current continues to hold; Director Business Development, between 2003 and 2007; and Assistant Director Transaction Services, from 2998 until 2003. Earlier, she worked for PwC as a Manager in the firm’s Assurance, Advisory and Transactions practice; was an ICAEW Trainee BDO Stoy Hayward, from 1991 until 1994; and was a Scientist at the Project Management Office R&D Operations at ICI Australia, where she started in 1990.
Spence holds a Bachelor of Science in Chemistry from the University of Nottingham and attended Kellogg School of Management and INSEAD where she studied Business Strategy.
Spence takes on the role of Global Life Sciences Industry Leader within EY’s Global Life Sciences sector practice. In her new role, Spence takes responsibility for the strategic direction of the practice, which contains some of the firm’s largest multinational clients. Spence takes over from Glen Giovannetti, who has been appointed to the role of Research and Insights Leader within EY Knowledge. Spence will be based in London.
Spence says, “This is an exciting time for the life sciences industry. Around the world, companies in the sector are looking to transform and innovate their strategies as they adapt to various health care reforms and the evolving industry landscape. New solutions will be required to meet the global challenges of sustainability of health care systems, ageing populations, chronic disease and increasing cost pressures. I look forward to working with our team of dedicated professionals to help our clients respond to these and other challenges.”